Nantahala Capital Management - HTG MOLECULAR DIAGNOSTICS IN ownership

Quarter-by-quarter ownership
Nantahala Capital Management ownership history of HTG MOLECULAR DIAGNOSTICS IN
ValueSharesWeighting
Q1 2022$397,000
-78.1%
285,963
-14.6%
0.02%
-71.9%
Q4 2021$1,816,000
-8.4%
335,015
-3.5%
0.06%
+3.2%
Q3 2021$1,982,000
-6.2%
347,171
-4.5%
0.06%
+3.3%
Q2 2021$2,113,000
+6.2%
363,6220.0%0.06%
+3.4%
Q1 2021$1,989,000
+14.2%
363,6220.0%0.06%
+7.4%
Q4 2020$1,742,000363,6220.05%
Other shareholders
HTG MOLECULAR DIAGNOSTICS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Samjo Capital LLC 381,713$1,828,0001.56%
Cowen Prime Services LLC 441,918$2,117,0000.94%
Nantahala Capital Management 363,622$1,742,0000.05%
GSA CAPITAL PARTNERS LLP 45,221$217,0000.04%
HighMark Wealth Management LLC 6,666$32,0000.03%
Tower Research Capital LLC (TRC) 10,572$51,0000.00%
Qube Research & Technologies Ltd 12,034$58,0000.00%
Squarepoint Ops LLC 25,597$123,0000.00%
Ironwood Financial, llc 103$00.00%
OSAIC HOLDINGS, INC. 24$00.00%
View complete list of HTG MOLECULAR DIAGNOSTICS IN shareholders